Vasculearn Network
Founded in 2006, the North American Thrombosis Forum (NATF) was born from a passion to educate both the medical community and the public about life-threatening blood clotting disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE). As our understanding of thrombosis evolved, so did our focus. It became clear that thrombosis was linked to a broader range of cardiovascular conditions, including atrial fibrillation, stroke, heart attack, cancer, diabetes, and obesity. In response, we expanded our educational efforts to better reflect these connections.
In 2024, our journey evolved once again and we became Vasculearn Network (VLN), a committed group of healthcare leaders alongside patients, caregivers, and families. Together, we’re educating people about real-world experiences and cutting-edge research to help the world better manage blood clots and related conditions with confidence.
Mission: Vasculearn Network is a nonprofit organization dedicated to improving the lives of those affected by blood clots and related diseases. Through our comprehensive resources and innovative programming, we strive to educate patients and clinicians about thrombosis and its complications.
Vision: To be the premier educational resource on blood clots and related diseases.
Vasculearn Network
Getting Your Cholesterol to Goal: The Growing List of Therapies
- 265 views
- September 17, 2024
- 4
Vasculearn Network
Hypertension: What it Is & Why it Matters
- 506 views
- September 17, 2024
- 6
Vasculearn Network
Obesity and Heart Health: Weighing the Facts
- 186 views
- September 17, 2024
- 4
Vasculearn Network
Nutrition After a Cardiovascular Event
- 5 views
- September 17, 2024
Vasculearn Network
Vaping Myths and Realities: Cardiovascular Health
- 662 views
- September 17, 2024
- 4
Vasculearn Network
Exercise After a Cardiovascular Event
- 101 views
- September 17, 2024
- 1
Vasculearn Network
Antithrombotic Therapy in Patients with Coexisting Cardiovascular & Gastrointestinal Disease
- 400 views
- September 17, 2024
- 3
The North American Thrombosis Forum (NATF)
An Internist's Perspective: Understanding Obesity and it's Management
- 807 views
- May 16, 2023
- 6
Vasculearn Network
A Cardiologist's Perspective: How I Treat My Patients with Obesity and CVD
- 52 views
- May 16, 2023
Vasculearn Network
How I Treat My Patients with Obesity and VTE - A Hematologist's Perspective
- 39 views
- May 16, 2023
Vasculearn Network
A Surgeon's Perspective: How I Treat My Anticoagulated Patients Undergoing Bariatric Surgery
- 56 views
- May 16, 2023
Vasculearn Network
Case Presentation: DOAC Use in a Patient with Obesity and Atrial Fibrillation
- 113 views
- May 16, 2023
Vasculearn Network
Case Presentation: What Anticoagulant a Hematologst Recommends to an Obese Patient
- 133 views
- May 16, 2023
- 2
Vasculearn Network
Case Presentation: How I Treat My Anticoagulated Patients Undergoing Bariatric Surgery
- 17 views
- May 16, 2023
Vasculearn Network
Current Treatments for LDL Lowering — and Why Patient Access Is So Important
- 735 views
- January 26, 2023
- 1
Vasculearn Network
Recent Cholesterol Guidelines and Integration into Clinical Practice
- 14,766 views
- January 26, 2023
- 40
Vasculearn Network
The Critical Importance of Lowering LDL-C in High-Risk Patients
- 424 views
- January 26, 2023
- 3
Vasculearn Network
Identifying Patients Who Would Benefit from PCSK9 Inhibitors
- 472 views
- January 26, 2023
- 1
Vasculearn Network
Heart Disease and Thrombosis in Pregnancy
- 93 views
- June 2, 2022
- 1
Vasculearn Network
COVID-19 and Blood Clots: 2022 Update
- 16 views
- March 18, 2022
Vasculearn Network
Clot Chronicles: Trial Takeaways from AHA 2021
- 259 views
- January 13, 2022
Vasculearn Network
Clot Chronicles: The SLICE Trial - Significance of Pulmonary Embolism in COPD Exacerbations
- 197 views
- January 13, 2022
- 2
Vasculearn Network
Clot Chronicles: Trial Takeaways from ESC 2021
- 272 views
- January 13, 2022
- 2
Vasculearn Network
The Perils of Discontinuing Anticoagulation in Afib — Findings from the GARFIELD-AF Registry
- 2,244 views
- January 13, 2022
- 9
Vasculearn Network
Clot Chronicles: Peripheral Artery Disease — What Clinicians Should Know
- 308 views
- January 13, 2022
- 4
Vasculearn Network
Stroke in Women: Can HTN, Diabetes and AFib Increase the Risk for Stroke? How Effective Is Anticoagulation?
- 41 views
- March 18, 2021
Vasculearn Network
Women's Cardiovascular Health: How to Evaluate D-dimer Tests in Patients with MINOCA to Exclude Pulmonary Embolism? Is There a Genetic Predisposition for MINOCA?
- 25 views
- March 18, 2021
Vasculearn Network
Vitamin D: How Does It Work? What's the “Right” Level?
- 25,584 views
- January 18, 2021
- 93
Vasculearn Network
Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?
- 604 views
- October 15, 2020
- 6
